Filing Details

Accession Number:
0000899140-24-001299
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-21 16:24:23
Reporting Period:
2024-11-19
Accepted Time:
2024-11-21 16:24:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808898 Benitec Biopharma Inc. BNTC () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569064 Suvretta Capital Management, Llc 540 Madison Avenue
7Th Floor
New York NY 10022
No No No No
1869640 Aaron Cowen C/O Suvretta Capital Management, Llc
540 Madison Avenue, 7Th Floor
New York NY 10022
No No No No
1939329 Averill Master Fund, Ltd. C/O Suvretta Capital Management, Llc
540 Madison Avenue, 7Th Floor
New York NY 10022
No No No No
2021243 Averill Madison Master Fund, Ltd. C/O Suvretta Capital Management, Llc
540 Madison Avenue, 7Th Floor
New York NY 10022
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2024-11-19 12,430 $9.73 7,895,815 No 4 P Indirect See footnotes
Common Stock, Par Value $0.0001 Per Share Acquisiton 2024-11-19 1,570 $9.73 947,238 No 4 P Indirect See footnotes
Common Stock, Par Value $0.0001 Per Share Acquisiton 2024-11-20 24,360 $10.22 7,920,175 No 4 P Indirect See footnotes
Common Stock, Par Value $0.0001 Per Share Acquisiton 2024-11-20 3,076 $10.22 950,314 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
No 4 P Indirect See footnotes
No 4 P Indirect See footnotes
No 4 P Indirect See footnotes
Footnotes
  1. Notes are included on Exhibit 99.1.
  2. Notes are included on Exhibit 99.1.
  3. Notes are included on Exhibit 99.1.
  4. Notes are included on Exhibit 99.1.
  5. Notes are included on Exhibit 99.1.